Acute Respiratory Failure Clinical Trial
Official title:
Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure: a Multicenter Observational Study
Severe SARS-CoV-2 infections are frequently associated with the acute respiratory distress syndrome (ARDS), which leads to a mortality of 30-40%. An altered type I interferon (IFN) response has been demonstrated in patients with severe COVID-19, together with a high viral load. The aim of the current work is, in a large cohort of patients with severe COVID-19 admitted in the ICU, to determine the prevalence of patients with positive anti-IFN antibodies and to determine their outcome, as compared to patients having negative anti-IFN antibodies.
Severe SARS-CoV-2 infections are frequently associated with the acute respiratory distress syndrome (ARDS), which leads to a mortality of 30-40%. An altered type I interferon (IFN) response has been demonstrated in patients with severe COVID-19, together with a high viral load. A recent study revealed that 10% of patients admitted in the intensive care unit (ICU) for severe COVID-19 had positive type I anti-IFN antibodies. Such finding has potentially important therapeutic implications, as patients having positive anti-IFN antibodies could benefit from targeted interventions, including plasmapheresis. The aim of the current work is, in a large cohort of patients with severe COVID-19 admitted in the ICU, to determine the prevalence of patients with positive anti-IFN antibodies and to determine their outcome, as compared to patients having negative anti-IFN antibodies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
| Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
| Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
| Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
| Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
| Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
| Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
| Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
| Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
| Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
| Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
| Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
| Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
| Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
| Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
| Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
| Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
| Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
| Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |